Medicare Enrolled
Dr. David Cosgrove, M.D.
Hematology & Oncology · Vancouver, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cosgrove from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cosgrove?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cosgrove
Dr. David Cosgrove is a hematology & oncology specialist in Vancouver, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cosgrove performed 44,018 Medicare services across 1,933 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cosgrove received a total of $23,535 from 13 pharmaceutical and/or device companies across 31 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cosgrove is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in WA
$23,535 industry payments
Medicare Practice Summary
Medicare Utilization ↗44,018
Medicare services
Top 6% in WA for hematology & oncology
1,933
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,317 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
7,810 | $2 | $21 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,650 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 7,200 | $43 | $147 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
7,140 | $0 | $6 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,840 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 1,560 | $18 | $70 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,530 | $22 | $194 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
752 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 650 | $0 | $25 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
616 | $8 | $34 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
585 | $10 | $60 |
| Anti-nausea injection (Aloxi/palonosetron) | 580 | $1 | $122 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
388 | $8 | $18 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
326 | $94 | $331 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
279 | $12 | $102 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
179 | $104 | $666 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
153 | $6 | $462 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 132 | $129 | $3,938 |
| PSA test (prostate cancer screening) | 122 | $18 | $88 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
94 | $24 | $137 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
93 | $9 | $52 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
88 | $22 | $148 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
88 | $11 | $90 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
80 | $48 | $295 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
70 | $22 | $151 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
68 | $135 | $465 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
62 | $69 | $70 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
59 | $1 | $7 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
57 | $16 | $76 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
51 | $55 | $235 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $60 | $234 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
47 | $18 | $93 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 45 | $276 | $550 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
44 | $1,133 | $3,524 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
44 | $6 | $29 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
42 | $48 | $774 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
40 | $185 | $1,006 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
40 | $13 | $56 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
36 | $20 | $120 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
35 | $2 | $19 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
32 | $52 | $324 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
31 | $45 | $273 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
31 | $1 | $9 |
| Iron level test | 30 | $6 | $25 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
30 | $9 | $33 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
23 | $25 | $242 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
22 | $10 | $71 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
19 | $25 | $135 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $125 | $509 |
| New patient office visit, complex (60-74 min) | 16 | $174 | $629 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
15 | $5 | $29 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
15 | $58 | $318 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
12 | $15 | $72 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.2% high complexity
76.2% medium
6.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,535
Total received (2018-2024)
Avg $3,362/year across 7 years
Top 16% in WA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
13
Companies
31
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18,320 (77.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,020 (21.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$195 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$195
2023
$16
2022
$1,850
2021
$400
2020
$3,200
2019
$4,022
2018
$13,852
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$160
Astellas Pharma US Inc
$29
PFIZER INC.
$6
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Biocompatibles, Inc.
$15,067
ARRAY BIOPHARMA INC
$3,200
E.R. Squibb & Sons, L.L.C.
$1,907
EMD Serono, Inc.
$1,250
Bayer HealthCare Pharmaceuticals Inc.
$900
Merck Sharp & Dohme LLC
$600
Daiichi Sankyo Inc.
$364
Boston Scientific Corporation
$160
Astellas Pharma US Inc
$29
Myovant Sciences Inc.
$24
Ipsen Biopharmaceuticals, Inc
$16
Gilead Sciences, Inc.
$12
PFIZER INC.
$6
Top 3 companies account for 85.7% of all-time payments
Associated products mentioned in payments ›
BRAFTOVI · INLYTA · KEYTRUDA · OPDIVO · ORGOVYX · Onivyde · SpaceOAR System · SpaceOAR VUE System - 10mL · Stivarga · TEPMETKO · THERASPHERE - BIO · THERASPHERE-BIO · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Hematology & oncology specialists within 10 mi
99
Per 100K population
19.4
County median income
$94,948
Nearest hospital
PEACEHEALTH SOUTHWEST MEDICAL CENTER
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cosgrove is a mixed practice specialist, with above-average Medicare volume (top 6% in WA), with speaking/promotional industry engagement in the top 16% of WA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cosgrove experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Cosgrove performed 7,810 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cosgrove receive payments from pharmaceutical companies?
Yes. Dr. Cosgrove received a total of $23,535 from 13 companies across 31 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cosgrove's costs compare to other hematology & oncology specialists in Vancouver?
Dr. Cosgrove's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cosgrove) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Vancouver
Browse hematology & oncology specialists in Vancouver ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in WA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in WA
Which WA hematology & oncology specialists receive the most from drug and device companies.
By company
Biocompatibles, Inc. Payments to Doctors
See all physicians who received payments from Biocompatibles, Inc.
By company
ARRAY BIOPHARMA INC Payments to Doctors
See all physicians who received payments from ARRAY BIOPHARMA INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology